Systematic Alpha Investments’s Pfizer PFE Stock Holding History

Systematic Alpha Investments’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.2M	Hold	424,515	–	–	0.27%	53
2026 Q1	$11.9M	Hold	424,515	–	–	0.42%	47
2025 Q4	$10.6M	Hold	424,515	–	–	0.33%	52
2025 Q3	$10.8M	Hold	424,515	–	–	0.36%	49
2025 Q2	$10.3M	Hold	424,515	–	–	0.37%	48
2025 Q1	$10.8M	Hold	424,515	–	–	0.41%	46
2024 Q4	$11.3M	Hold	424,515	–	–	0.41%	44
2024 Q3	$12.3M	Hold	424,515	–	–	0.45%	44
2024 Q2	$11.9M	Hold	424,515	–	–	0.45%	42
2024 Q1	$11.8M	Hold	424,515	–	–	0.47%	42
2023 Q4	$12.2M	Hold	424,515	–	–	0.55%	39
2023 Q3	$14.1M	Hold	424,515	–	–	0.7%	33
2023 Q2	$15.6M	Hold	424,515	–	–	0.75%	32
2023 Q1	$17.3M	Hold	424,515	–	–	0.91%	29
2022 Q4	$21.8M	Hold	424,515	–	–	1.1%	21
2022 Q3	$18.6M	Hold	424,515	–	–	1.12%	23
2022 Q2	$22.3M	Hold	424,515	–	–	1.26%	21
2022 Q1	$22M	Hold	424,515	–	–	1.07%	25
2021 Q4	$25.1M	Hold	424,515	–	–	1.16%	21
2021 Q3	$18.6M	Hold	424,515	–	–	0.81%	28
2021 Q2	$20.5M	Buy	424,515 +23,515	+6%	+$914K	0.93%	27
2021 Q1	$14.5M	Hold	401,000	–	–	0.93%	27
2020 Q4	$14.8M	Buy	+401,000	New	+$14.7M	1.61%	21

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Systematic Alpha Investments's PFE Position: Q2 2026 in Review

Systematic Alpha Investments held its Pfizer (PFE) position steady in Q2 2026 at 424,515 shares worth $10.2M. The position accounts for 0.27% of the portfolio, ranked #53.

Systematic Alpha Investments first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $25.1M in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Systematic Alpha Investments held 424,515 shares of Pfizer worth $10.2M as of Q2 2026.
Systematic Alpha Investments left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.27% of Systematic Alpha Investments's portfolio in Q2 2026, its #53 holding.
Systematic Alpha Investments first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
Systematic Alpha Investments's Pfizer position peaked at $25.1M in Q4 2021.
2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Systematic Alpha Investments's 13F filing for Q2 2026, filed 13 Aug 2026.